Literature DB >> 9483441

[Therapy of chronic cardiac insufficiency with ACE inhibitors versus AT1 receptor antagonists. Is there a difference?].

B Schieffer1, H Drexler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9483441     DOI： 10.1007/BF03044289

Source DB:  PubMed          Journal:  Herz        ISSN： 0340-9937            Impact factor:   1.443


× No keyword cloud information.
  18 in total

1.  Evaluation of Losartan in the Elderly (ELITE) Trial: clinical implications.

Authors:  B Pitt
Journal:  Eur Heart J       Date:  1997-08       Impact factor: 29.983

Review 2.  Angiotensin II receptors and angiotensin II receptor antagonists.

Authors:  P B Timmermans; P C Wong; A T Chiu; W F Herblin; P Benfield; D J Carini; R J Lee; R R Wexler; J A Saye; R D Smith
Journal:  Pharmacol Rev       Date:  1993-06       Impact factor: 25.468

3.  Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart.

Authors:  H Urata; K D Boehm; A Philip; A Kinoshita; J Gabrovsek; F M Bumpus; A Husain
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

4.  Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.

Authors:  B Schieffer; A Wirger; M Meybrunn; S Seitz; J Holtz; U N Riede; H Drexler
Journal:  Circulation       Date:  1994-05       Impact factor: 29.690

5.  Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system?

Authors:  R T Gansevoort; D de Zeeuw; P E de Jong
Journal:  Kidney Int       Date:  1994-03       Impact factor: 10.612

6.  Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure.

Authors:  S S Gottlieb; K Dickstein; E Fleck; J Kostis; T B Levine; T LeJemtel; M DeKock
Journal:  Circulation       Date:  1993-10       Impact factor: 29.690

7.  Development and prevention of skeletal muscle structural alterations after experimental myocardial infarction.

Authors:  B Schieffer; K C Wollert; M Berchtold; K Saal; E Schieffer; B Hornig; U N Riede; H Drexler
Journal:  Am J Physiol       Date:  1995-11

Review 8.  Effects of angiotensin receptor antagonists in heart failure: clinical and experimental aspects.

Authors:  V Regitz-Zagrosek; M Neuss; E Fleck
Journal:  Eur Heart J       Date:  1995-12       Impact factor: 29.983

9.  Losartan in heart failure. Hemodynamic effects and tolerability. Losartan Hemodynamic Study Group.

Authors:  I Crozier; H Ikram; N Awan; J Cleland; N Stephen; K Dickstein; M Frey; J Young; G Klinger; L Makris
Journal:  Circulation       Date:  1995-02-01       Impact factor: 29.690

10.  Survival after myocardial infarction in rats: captopril versus losartan.

Authors:  J J Milavetz; T E Raya; C S Johnson; E Morkin; S Goldman
Journal:  J Am Coll Cardiol       Date:  1996-03-01       Impact factor: 24.094
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.